Anagrelide

In the US, Anagrelide (anagrelide systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Chronic Myelogenous Leukemia and Thrombocythemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX35

CAS registry number (Chemical Abstracts Service)

0068475-42-3

Chemical Formula

C10-H7-Cl2-N3-O

Molecular Weight

256

Therapeutic Category

Antiplatelet agent: Phosphodiesterase inhibitor

Chemical Name

6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one (WHO)

Foreign Names

  • Anagrelidum (Latin)
  • Anagrelid (German)
  • Anagrelide (French)
  • Anagrelida (Spanish)

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)